CRITICAL DIAGNOSTICS
Critical Diagnostics is a company on the cutting edge of this change, focused on the discovery, development, and commercialization of novel biomarkers in cardiovascular diseases. Their lead product, the Presage® ST2 Assay, has received FDA clearance and is CE Marked in Europe. This simple, non-invasive test measures for soluble ST2 in the blood, which can aid physicians in risk assessment of heart failure patients. Soluble ST2 has now been published in more than 100 peer-reviewed articles and... scientific posters studying more than 36,000 patients. These clinical studies have demonstrated that high levels of soluble ST2 are predictive of adverse patient outcomes and death in a broad spectrum of cardiovascular disease. They have further shown that the prognostic information from soluble ST2 is independent and provides added information to the cardiac biomarkers commonly used today, including the natriuretic peptides, BNP and NT-proBNP. Critical Diagnostics was founded in 2004. The Company licensed intellectual property discovered in 2002 at Brigham and Women's Hospital relating to ST2, for which it now holds the exclusive worldwide rights. The company has since expanded its intellectual property portfolio and holds several issued patents in the US and abroad as well as numerous patents pending.
CRITICAL DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2004-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.criticaldiagnostics.com
Total Employee:
11+
Status:
Active
Contact:
8667158009
Total Funding:
11.07 M USD
Technology used in webpage:
Viewport Meta SPF Google Font API Google Analytics Apache Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Analytics Classic GoDaddy
Similar Organizations
Acura Pharmaceuticals
Acura Pharmaceuticals develops and commercializes tamper-resistant products for medication abuse and misuse.
AltheaDx
AltheaDx offers molecular diagnostics and PCR-based services such as molecular biomarker discovery, assay development and assay validation.
Arquer Diagnostics
Arquer Diagnostics is a diagnostics company focused on the development and commercialisation of a non-invasive immunoassay diagnostic test.
Astute Medical
Astute Medical provides diagnosis of high-risk medical conditions through the identification and validation of protein biomarkers.
Athena Diagnostics
Athena Diagnostics is a reference laboratory dedicated to the development and commercialization of diagnostic testing for neurological
Bio-Rad Laboratories
Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of
BioFire Diagnostics
BioFire Diagnostics is a biotech company that detects pathogens and mutations for molecular diagnostics.
Dominion Diagnostics
Dominion Diagnostics is a medical laboratory that provides clinical quantitative urine drug testing and medication monitoring services.
Eon Biotechnology
Novel Health Diagnostics fused with Identity management aided by Computer Vision (Artificial Intelligence) to provide tamper proof EHR & EMR
Eurobio-Scientific
Eurobio-Scientific expertise in discovery to commercialization of specialty diagnostic solutions & products for research in life-science.
Factorial Diagnostics
Factorial Diagnostics is focused on leveraging its novel NGS library to commercialize high resolution, multi-omic, cancer diagnostic assays.
Fujirebio Diagnostics
Fujirebio Diagnostics, Inc. is a world leader in the production of in vitro diagnostics, and biomarkers.
Lev-El Diagnostics
Lev-El Diagnostics is a med-tech company specializing in noninvasive detection of cardiovascular diseases.
Metabolomic Diagnostics
Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases
MGP Diagnostics
MGP Diagnostics AS conducts research on a new biomarker for cardiovascular disease.
NanoCellect Biomedical
NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.
Stage I Diagnostics
Stage I Diagnostics, Inc. (Stage I) is a Delaware C-Corp founded in 2005 by Timothy J. O’Brien, PhD.
Suraksha Diagnostics
Suraksha Diagnostics is a leading diagnostic services chain providing pathology and radiology services.
Synaps Dx
Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimer’s Disease.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.criticaldiagnostics.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Critical Diagnostics"
Critical Diagnostics - Crunchbase Company Profile
Critical Diagnostics is a company on the cutting edge of this change, focused on the discovery, development, and commercialization of novel biomarkers in …See details»
Critical Diagnostics - LinkedIn
Critical Diagnostics | 454 followers on LinkedIn. Critical Diagnostics helps physicians optimize patient care in cardiovascular diseases, such as heart failure. Our high sensitivity Presage® ST2 ...See details»
Critical Diagnostics - PitchBook
Critical Diagnostics General Information Description. Operator of a cardiac biomarker company biomarkers intended to treat cardiovascular diseases. …See details»
Critical Diagnostics - Company Profile - Tracxn
Critical Diagnostics - Developer of biomarkers-based tests for cardiovascular diseases diagnostics. Raised a total funding of $11.1M over 3 rounds from 1 investor. Founded by …See details»
Critical Diagnostics - Overview, News & Similar companies
Who is Critical Diagnostics. Critical Diagnostics ( www.criticaldiagnostics.com ) develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while …See details»
Critical Diagnostics - Craft
Critical Diagnostics is a company that develops solutions for patient care in cardiovascular diseases, such as heart failure. It offers the Presage ST2 Assay non-invasive test that …See details»
Critical Diagnostics - Company Profile & Staff Directory - ContactOut
Critical Diagnostics helps physicians optimize patient care in cardiovascular diseases, such as heart failure. Our high sensitivity Presage® ST2 Assay measures the level of soluble ST2 in …See details»
Cardiac Biomarker Company Critical Diagnostics ... - Business Wire
Jan 3, 2018 Critical Diagnostics Dennis Dalangin +1 (877) 700-1250 [email protected] Contacts Critical Diagnostics Dennis Dalangin +1 (877) …See details»
Critical Diagnostics – Funding, Valuation, Investors, News
Jan 3, 2018 Critical Diagnostics helps physicians optimize patient care in cardiovascular diseases, such as heart failure. Our high sensitivity Presage® ST2 Assay measures the level …See details»
Critical Diagnostics Profile - Medical XPRT
The world is changing all around us. Healthcare is constantly changing and evolving, as new and better ways of providing patient care are helping to save lives and improve the quality of life for …See details»
Critical Diagnostics - Updates, News, Events, Signals & Triggers
Critical Diagnostics focuses on cardiovascular disease biomarkers, developing methods to predict mortality and detect severe disease through circulating ST2 and IL-33 concentrations.See details»
IDS Medical Systems | Our Partner - Critical Diagnostics
Critical Diagnostics is a company that focuses on the discovery, development, and commercialization of novel biomarkers in cardiovascular diseases. Cr...See details»
Cardiac IVD Company Critical Diagnostics Expands Its Global …
Apr 11, 2013 SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, and makers of the Presage® ST2 Assay, today …See details»
Critical Care Diagnostics Company Profile -Sales, Contacts, …
Critical Care Diagnostics Inc (trade name Critical Diagnostics) is in the In Vitro Diagnostics business. View competitors, revenue, employees, website and phone number.See details»
FDA Clearance for Critical Diagnostics' Presage® ST2 Assay
Dec 15, 2011 SAN DIEGO--(BUSINESS WIRE)-- Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, announced today that the U.S. Food and Drug …See details»
Critical Diagnostics | Top In-Vitro Diagnostic Technology Solution ...
With the help of ST2, clinicians can be more precise in providing care that slows down the progression of cardiac disease. Along with improving the quality of care, the availability of a …See details»
Cardiac Biomarker Company Critical Diagnostics Completes $8.5 …
Jan 3, 2018 Critical Diagnostics Dennis Dalangin +1 (877) 700-1250 [email protected]. Contacts. Critical Diagnostics Dennis Dalangin +1 (877) …See details»
Critical Diagnostics Widens its Footprint in The Asia Pacific Region ...
Aug 20, 2012 Critical Diagnostics James Snider President, 877-700-1250 [email protected]. Contacts. Critical Diagnostics James Snider President, 877 …See details»
Presage® ST2 – Heart Failure Prognosis - Sopachem Diagnostics
White Paper report, The Presage ST2 Assay is an Effective Tool to Reduce 30-Day Heart Failure Hospital Readmissions, available through Critical Diagnostics:www.criticaldiagnostics.com; …See details»
Critical Diagnostics’ Presage® ST2 Assay Cardiac Biomarker Test ...
Mar 24, 2015 Critical Diagnostics Dennis Dalangin, +1 877-700-1250 VP Marketing [email protected] Contacts Critical Diagnostics Dennis Dalangin, +1 877-700 …See details»